GERN:NASDAQ
Geron Corp
$1.31
arrow_downward
-4.38%(-0.060) 1D
$1.31
0.00% (0.00)
bedtimeAfter hours
Closed: Sep 15, 4:00:01 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GERN...
Open
$1.37
High
$1.37
Low
$1.30
Mkt. cap
841.64M
Avg. vol.
11.10M
Volume
16.49M
52-wk high
$2.01
52-wk low
$1.04
EPS
-$0.10
Beta
0.61
Shares outstanding
642.47M
No. of employees
258
Open
$1.37
High
$1.37
Low
$1.30
Mkt. cap
841.64M
Avg. vol.
11.10M
Volume
16.49M
52-wk high
$2.01
52-wk low
$1.04
EPS
-$0.10
Beta
0.61
Shares outstanding
642.47M
No. of employees
258
News stories
From web sources and news partners
TradingView
·
2 days ago
Geron Sees RYTELO Revenue Near High End of 2026 Guidance as Community Use Expands
Profile
Geron Corporation is a biotechnology company located in Foster City, California which specializes in developing and commercializing therapeutic products for cancer that inhibit telomerase. Wikipedia
About Geron Corp
CEOJohn A Scarlett
Employees258
Founded1990
HeadquartersMenlo Park, California, United States
SectorBiotechnology
Websitegeron.com